These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12670909)

  • 21. Losses of chromosomes 1p and 19q are rare in pediatric oligodendrogliomas.
    Kreiger PA; Okada Y; Simon S; Rorke LB; Louis DN; Golden JA
    Acta Neuropathol; 2005 Apr; 109(4):387-92. PubMed ID: 15739101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer chemopreventive activity of a mixture of Chinese herbs (antitumor B) in mouse lung tumor models.
    Zhang Z; Wang Y; Yao R; Li J; Yan Y; La Regina M; Lemon WL; Grubbs CJ; Lubet RA; You M
    Oncogene; 2004 May; 23(21):3841-50. PubMed ID: 15021904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome-wide SNP analysis of Tg.AC transgenic mice reveals an oncogenic collaboration between v-Ha-ras and Ink4a, which is absent in p53 deficiency.
    Leder A; McMenamin J; Zhou F; Moran JL; Beier DR; Leder P
    Oncogene; 2008 Apr; 27(17):2456-65. PubMed ID: 17952114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas.
    Cuatrecasas M; Catasus L; Palacios J; Prat J
    Am J Surg Pathol; 2009 Apr; 33(4):556-67. PubMed ID: 19033864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Influence of molecular-genetic factors on prognosis in patients with oligodendroglial tumors].
    Absaliamova OV; Korshunov AG; Loshakov VA; Kobiakov GL; Golanov AV; Urakov SV; Amanov RD; Lichinitser MR
    Zh Vopr Neirokhir Im N N Burdenko; 2009; (1):17-23; discussion 23-4. PubMed ID: 19507310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular analysis of chromosome 1, 10 and 19 abnormalities in human oligodendroglial tumors: relationship between frequency of LOH grade, age and gender.
    Gresner SM; Rieske P; Wozniak K; Piaskowski S; Jaskolski DJ; Skowronski W; Golanska E; Sikorska B; Liberski PP
    Clin Neuropathol; 2006; 25(1):18-24. PubMed ID: 16465770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesis.
    Uhrbom L; Kastemar M; Johansson FK; Westermark B; Holland EC
    Cancer Res; 2005 Mar; 65(6):2065-9. PubMed ID: 15781613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of EGFR, HER2, TP53, and KRAS mutations of p14arf expression in non-small cell lung cancers in relation to smoking history.
    Mounawar M; Mukeria A; Le Calvez F; Hung RJ; Renard H; Cortot A; Bollart C; Zaridze D; Brennan P; Boffetta P; Brambilla E; Hainaut P
    Cancer Res; 2007 Jun; 67(12):5667-72. PubMed ID: 17575133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Histological and molecular classification of gliomas].
    Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
    Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Shared epigenetic mechanisms in human and mouse gliomas inactivate expression of the growth suppressor SLC5A8.
    Hong C; Maunakea A; Jun P; Bollen AW; Hodgson JG; Goldenberg DD; Weiss WA; Costello JF
    Cancer Res; 2005 May; 65(9):3617-23. PubMed ID: 15867356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GFAP promoter driven transgenic expression of PDGFB in the mouse brain leads to glioblastoma in a Trp53 null background.
    Hede SM; Hansson I; Afink GB; Eriksson A; Nazarenko I; Andrae J; Genove G; Westermark B; Nistér M
    Glia; 2009 Aug; 57(11):1143-53. PubMed ID: 19115382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of hypoxia-related tissue factors correlates with diminished survival of adjuvantly treated patients with chromosome 1p aberrant oligodendroglial neoplasms and therapeutic implications.
    Birner P; Preusser M; Gelpi E; Berger J; Gatterbauer B; Ambros IM; Ambros PF; Acker T; Plate KH; Harris AL; Hainfellner JA
    Clin Cancer Res; 2004 Oct; 10(19):6567-71. PubMed ID: 15475445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorescent in situ hybridization on isolated tumor cell nuclei: a sensitive method for 1p and 19q deletion analysis in paraffin-embedded oligodendroglial tumor specimens.
    Gelpi E; Ambros IM; Birner P; Luegmayr A; Drlicek M; Fischer I; Kleinert R; Maier H; Huemer M; Gatterbauer B; Anton J; Rössler K; Budka H; Ambros PF; Hainfellner JA
    Mod Pathol; 2003 Jul; 16(7):708-15. PubMed ID: 12861068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epstein-Barr virus latent membrane protein 1 (CAO) up-regulates VEGF and TGF alpha concomitant with hyperlasia, with subsequent up-regulation of p16 and MMP9.
    Stevenson D; Charalambous C; Wilson JB
    Cancer Res; 2005 Oct; 65(19):8826-35. PubMed ID: 16204053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. INK4a/Arf is required for suppression of EGFR/DeltaEGFR(2-7)-dependent ERK activation in mouse astrocytes and glioma.
    Lachat Y; Diserens AC; Nozaki M; Kobayashi H; Hamou MF; Godard S; De Tribolet N; Hegi ME
    Oncogene; 2004 Sep; 23(41):6854-63. PubMed ID: 15273738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenging diagnosis: oligodendroglioma versus extraventricular neurocytoma.
    Mut M; Güler-Tezel G; Lopes MB; Bilginer B; Ziyal I; Ozcan OE
    Clin Neuropathol; 2005; 24(5):225-9. PubMed ID: 16167546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene dosage and mutational analyses of EGFR in oligodendrogliomas.
    Franco-Hernandez C; Martinez-Glez V; Alonso ME; De Campos JM; Isla A; Vaquero J; Gutierrez M; Rey JA
    Int J Oncol; 2007 Jan; 30(1):209-15. PubMed ID: 17143531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional genomic analysis identified epidermal growth factor receptor activation as the most common genetic event in oral squamous cell carcinoma.
    Sheu JJ; Hua CH; Wan L; Lin YJ; Lai MT; Tseng HC; Jinawath N; Tsai MH; Chang NW; Lin CF; Lin CC; Hsieh LJ; Wang TL; Shih IeM; Tsai FJ
    Cancer Res; 2009 Mar; 69(6):2568-76. PubMed ID: 19276369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between genetic alteration and long-term clinical outcome of patients with oligodendroglial tumors, with identification of a consistent region of deletion on chromosome arm 1p.
    Hashimoto N; Murakami M; Takahashi Y; Fujimoto M; Inazawa J; Mineura K
    Cancer; 2003 May; 97(9):2254-61. PubMed ID: 12712480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background.
    Ackermann J; Frutschi M; Kaloulis K; McKee T; Trumpp A; Beermann F
    Cancer Res; 2005 May; 65(10):4005-11. PubMed ID: 15899789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.